Fatigue, Sleep, and Ammonia Clearance

How the amino acid L-ornithine reduces physical fatigue, improves sleep quality, and helps the body clear toxic ammonia through the urea cycle

L-ornithine is an amino acid your body makes naturally, sitting at the center of the urea cycle — the process that converts toxic ammonia into harmless urea, which you excrete in urine. When ammonia builds up, whether from intense exercise, high protein intake, or liver stress, it causes fatigue, brain fog, and poor sleep. Supplementing with L-ornithine helps accelerate this clearance, and research shows real benefits: reduced physical fatigue, better sleep quality, and lower cortisol levels in stressed adults [1][2]. It's a modest supplement with a specific, well-understood mechanism, particularly useful for active people and those who struggle with fatigue-related sleep disruption.

How L-Ornithine Works

L-ornithine plays a structural role in the urea cycle, the liver's primary route for neutralizing ammonia. Ammonia is a byproduct of protein metabolism — every time your body breaks down amino acids for energy or muscle repair, ammonia is released. Normally the liver processes it quickly, but when the load is high (during intense exercise, heavy protein intake, or when the liver is under stress), ammonia can spill into the bloodstream and reach the brain, where it interferes with neurotransmitter function and energy production.

Supplemental L-ornithine gives the urea cycle more substrate to work with, allowing the liver to process ammonia more efficiently. This has downstream effects on several systems:

Physical fatigue: High blood ammonia is a driver of peripheral and central fatigue during exercise. By reducing ammonia accumulation, L-ornithine helps muscles maintain performance and recover faster [3].
Sleep and cortisol: L-ornithine appears to modulate the stress axis. In clinical trials, supplementation lowered the cortisol-to-DHEA-S ratio — a marker of HPA axis overactivation — and improved both subjective and objective sleep quality [1].
Energy metabolism: Research shows ornithine may shift fuel use toward fat oxidation during sustained activity, sparing glucose and reducing the metabolic byproducts that accelerate fatigue [2].

There is also an interaction with GABA pathways. Animal research suggests ornithine can act at GABA-A receptors in a calming direction, which may partly explain its stress-reducing effects in humans, though this mechanism is not yet fully established in clinical research.

The Ammonia-Fatigue Connection

Most people don't think about ammonia as a fatigue driver, but the link is well-established in exercise physiology. During high-intensity or prolonged exercise, skeletal muscle produces substantial ammonia from AMP deamination (breaking down adenosine monophosphate for energy). This ammonia enters the bloodstream, and when plasma ammonia rises significantly, it impairs:

Glutamate cycling in the brain, disrupting neurotransmitter balance
The citric acid cycle in muscle cells, reducing energy output
The arousal system, causing the feeling of "central fatigue" — the heavy, slowing-down sensation late in a workout

L-ornithine supplementation before exercise has been shown to increase ammonia buffering capacity, reducing peak plasma ammonia and helping it clear more quickly after the session ends [3]. This doesn't necessarily make you faster, but it may reduce the feeling of exhaustion during and after hard training.

Sleep Quality and Stress Reduction

The link between L-ornithine and sleep is less obvious than the ammonia story, but the evidence is genuine. In a randomized controlled trial with 52 healthy working adults, 400 mg/day of L-ornithine for eight weeks significantly reduced the Athens Insomnia Scale score at four weeks compared to placebo, alongside reductions in serum cortisol and the cortisol/DHEA-S ratio [1]. Anger and fatigue scores on mood assessments also improved.

Why would an amino acid involved in liver detoxification affect sleep? One plausible explanation: elevated ammonia, even at subclinical levels, disrupts the sleep-wake transition and sleep architecture. By keeping ammonia low, ornithine may allow the normal sleep cycle to proceed without biochemical interference. The cortisol reduction is a separate but complementary effect — lower cortisol at night is a prerequisite for deep, restorative sleep.

Practical note: For sleep benefits, L-ornithine is generally taken in the evening, 30–60 minutes before bed. This timing aligns with when liver ammonia clearance activity can be most beneficial.

Dosage and Sources

Supplement form: Most studies use 400–2000 mg/day. For sleep and stress, 400 mg/day has shown efficacy. For exercise-related ammonia reduction, higher doses (2000–6000 mg taken before or on training days) have been used.
Form: L-ornithine hydrochloride is the most common and studied form. L-ornithine-L-aspartate (LOLA) is a pharmaceutical formulation used clinically for liver disease.
Food sources: L-ornithine is not abundant in common foods. Small amounts are found in fish, eggs, meat, and pumpkin seeds, but dietary intake is far below supplement doses.
Safety: Well-tolerated at doses up to 6000 mg in short-term studies. Higher doses (above 2000 mg) may cause mild gastrointestinal discomfort in some people. Not recommended during pregnancy without medical supervision.
Timing: Evening or pre-sleep for sleep/stress benefits; pre-workout or daily dosing for exercise recovery.

See our L-Citrulline page for a related amino acid that also influences the ornithine-arginine pathway and supports endurance performance. For complementary sleep support, see Glycine and L-Theanine.

Evidence Review

Sleep Quality and Stress Hormones — Randomized Controlled Trial

Miyake et al. (2014, PMID 24889392) conducted a randomized, double-blind, placebo-controlled trial in 52 apparently healthy Japanese adults who reported chronic mild fatigue and stress. Participants were randomized to 400 mg/day L-ornithine or placebo for eight weeks. The primary outcome measure was the Athens Insomnia Scale (AIS); secondary measures included salivary and serum cortisol, DHEA-S, and the Profile of Mood States (POMS). The L-ornithine group showed significant improvement on the AIS at four weeks (P < 0.05 vs. placebo), with continued benefit at eight weeks. Serum cortisol levels and the cortisol-to-DHEA-S ratio decreased significantly in the L-ornithine group compared to placebo, indicating reduced HPA axis activity. The POMS subscale for anger was also significantly lower in the ornithine group. Limitations include the relatively small sample (n = 52), the exclusively Japanese working adult population, and the lack of objective sleep measures such as actigraphy. The dose of 400 mg/day is modest; it's possible higher doses would show stronger effects. Despite these limitations, the design is rigorous for a supplement trial, and the biomarker data (cortisol, DHEA-S) provide mechanistic support beyond self-report alone.

Physical Fatigue Attenuation — Crossover Trial

Sugino et al. (2008, PMID 19083482) used a double-blind, placebo-controlled, 2-way crossover design with 17 healthy adults who underwent a standardized physical load test followed by an exhaustive arm exercise protocol on two occasions separated by a washout period. Participants received either L-ornithine (2000 mg/day for seven days, then 6000 mg on the test day as L-ornithine hydrochloride) or placebo. The primary outcome was subjective fatigue on a visual analog scale. L-ornithine significantly attenuated the subjective feeling of fatigue compared with placebo (P < 0.05), with a particularly pronounced effect in female participants. Metabolic analysis showed differences in lipid and amino acid profiles consistent with increased fat oxidation and altered nitrogen handling — suggesting ornithine promoted more efficient energy metabolism rather than simply masking fatigue. This study used a relatively high dose (6000 mg on the test day), which may limit generalizability to typical supplement users taking 400–2000 mg daily. The crossover design strengthens within-subject comparisons, and the metabolic data support a plausible mechanism rather than a simple psychological effect.

Ammonia Metabolism During Exercise — Controlled Ergometer Study

Demura et al. (2010, PMID 20717126) examined the effects of L-ornithine hydrochloride ingestion on ammonia metabolism and exercise performance during an incremental exhaustive cycling protocol in 12 trained male subjects. Participants performed two trials (L-ornithine vs. placebo, crossover) in which they received a single pre-exercise dose and completed an incremental maximal bicycle ergometer test. The primary findings were that L-ornithine supplementation did not significantly improve exercise performance (VO2max or time to exhaustion), but significantly improved ammonia buffering — plasma ammonia rose less during exercise and recovered more rapidly after exercise in the L-ornithine condition. The implication is that L-ornithine's primary benefit in exercise is metabolic recovery rather than acute performance enhancement. This finding is consistent with the fatigue-reduction data (Sugino 2008): the mechanism appears to be that faster ammonia clearance allows muscles and the nervous system to recover, reducing cumulative fatigue across training sessions rather than boosting a single effort. The study's limitations include the small sample (n = 12), single-dose protocol, and exclusively male trained subjects.

L-Ornithine L-Aspartate for Hepatic Encephalopathy — Systematic Review and Meta-Analysis

Butterworth et al. (2018, PMID 30302048) performed a systematic review and meta-analysis of randomized controlled trials of L-ornithine L-aspartate (LOLA) for hepatic encephalopathy and hyperammonemia in cirrhosis patients. The analysis included trials using both intravenous (n = 520 patients) and oral (n = 189 patients) formulations. The meta-analysis found that LOLA significantly reduced fasting blood ammonia compared to placebo (mean difference = −17.50 μmol/L, 95% CI: −27.73 to −7.26, P = 0.0008). Both formulations were effective: intravenous LOLA reduced ammonia by a mean difference of −27.16 μmol/L (95% CI: −44.77 to −9.56), while oral LOLA reduced it by −8.44 μmol/L (95% CI: −12.42 to −4.46). Mental state grade, cognitive function tests, and health-related quality of life also improved significantly with LOLA treatment. This meta-analysis is most relevant to the clinical (liver disease) context, using the combined LOLA formulation rather than L-ornithine alone. However, it establishes that the mechanism — L-ornithine accelerating urea cycle activity to clear ammonia — works robustly in humans, even in the difficult setting of liver impairment. For healthy adults, the ammonia burden is far lower, which is consistent with the more modest benefits seen in the exercise and sleep trials.

Overall Evidence Assessment

The evidence for L-ornithine is coherent and mechanistically grounded: ammonia is a genuine source of fatigue, disrupted sleep, and cognitive fog; L-ornithine accelerates its clearance via the urea cycle; and clinical trials confirm downstream benefits on fatigue, sleep quality, and cortisol regulation. The quality of evidence is moderate — the healthy adult trials are small and mostly Japanese (limiting ethnic generalizability), and the strongest mechanistic data (LOLA meta-analysis) uses a different formulation in a clinical population. The supplement has a good safety record in the doses studied. The most compelling use cases are: people who feel persistently fatigued despite adequate sleep, those whose sleep is non-restorative, and athletes seeking to improve recovery between training sessions. Claims about large performance improvements are not supported by the data; the benefits are subtler — a reduction in accumulated metabolic fatigue rather than acute ergogenic effects.

References

Randomised controlled trial of the effects of L-ornithine on stress markers and sleep quality in healthy workersMiyake M, Kirisako T, Kokubo T, Miura Y, Morishita K, Okamura H, Tsuda A. Nutrition Journal, 2014. PubMed 24889392 →
L-ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolismSugino T, Shirai T, Kajimoto Y, Kajimoto O. Nutrition Research, 2008. PubMed 19083482 →
The effect of L-ornithine hydrochloride ingestion on performance during incremental exhaustive ergometer bicycle exercise and ammonia metabolism during and after exerciseDemura S, Morishita K, Yamada T, Yamaji S, Ohuchi T. European Journal of Clinical Nutrition, 2010. PubMed 20717126 →
Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled TrialsButterworth RF, Kircheis G, Hilger N, McPhail MJW. Journal of Clinical and Experimental Hepatology, 2018. PubMed 30302048 →